Product Name | Abiraterone Ethyl Ether;AB-IMP-12 |
---|---|
CAS | 2484719-14-2 |
Formula | C26H35NO |
MW | 377.56 |
Appearance | White to off-white solid |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
2 mg | In-stock | $166.00 | Visible after login | |
5 mg | In-stock | $226.00 | Visible after login | |
10 mg | In-stock | $388.00 | Visible after login | |
20 mg | In-stock | $686.00 | Visible after login |
Product Name | Abiraterone Ethyl Ether;AB-IMP-12 |
---|---|
CAS | 2484719-14-2 |
Formula | C26H35NO |
MW | 377.56 |
Appearance | White to off-white solid |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Abiraterone Ethyl Ether is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17, 20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.